Welcome to LookChem.com Sign In|Join Free

Hubei Moxin Biotechnology Co., Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
1st
years
Home>>Products>>Baloxavir Impurity

Products Categories

Product Certification&
Enterprise Certification

More Detail

Hubei Moxin Biotechnology Co., Ltd

Country: China (Mainland)

Business Type:Lab/Research institutions

Ms.Du

Tel: +86-173-20513646

Mobile: 17320513646

Tel: +86-173-20513646

Fax:

URL: http://www.molcoo.com

Province/state: Hu Bei

City: Wuhan

Street: Company address: Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China

MaxCard:


qq Contact Suppliers

Baloxavir Impurity

  • FOB Price: USD: 10.00-10.00 /Milligram Get Latest Price
  • Min.Order: 10 Milligram
  • Payment Terms: T/T
  • Available Specifications:

    1(10.0-10000)Milligram

Contact Supplier

Product Details

Keywords

  • Baloxavir Impurity
  • C27H23F2N3O7S
  • Baloxavir

Quick Details

  • ProName: Baloxavir Impurity
  • Molecular Formula: C27H23F2N3O7S
  • Appearance: White to off white powder
  • Application: experiment research
  • DeliveryTime: prompt delivery
  • PackAge: Food bags, aluminum foil bags
  • Port: Shenzhen/hongkong
  • ProductionCapacity: 5000 Gram/Year
  • Purity: 99%+ HPLC
  • Storage: cool and dry
  • Transportation: DHL,EMS,TNT,UPS,EMS,by air,by sea;
  • LimitNum: 10 Milligram
  • Moisture Content: 0.1%
  • Impurity: 0.1%

Superiority

We supply over 20000 types of spot impurity reference materials, with sufficient supply and same day delivery to meet customers' urgent needs for replenishment at any time. The company has its own research and development center and laboratory, and the team members have over ten years of experience in developing drug impurity reference standards. Our website www.molcoo.com covers over 98% of cutting-edge generic drug projects, with complete structural formulas that greatly save customers time in impurity structure analysis and inference. All products undergo strict quality control testing and provide relevant information such as COA, H-NMR, C-NMR, MS/GC-MS, HPLC/GC purity, QNMR quantification, TGA thermogravimetric analysis, IR infrared, UV ultraviolet, two-dimensional (COSY, NOESY, HMBC, HMQC), etc. These structural confirmation spectra ensure quality and reliability. Our products have a wide range of categories, fast delivery time, good quality, and low prices, which can quickly solve various customer needs such as replenishment and consistency evaluation.

Details

Baloxavir Impurity

 

 

Product Information

  • Product Code:B040031

  • English Name:Baloxavir Impurity 31

  • English Alias:(((S)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl)oxy)methyl methyl carbonate

  • CAS No.:[Not Available]

  • Molecular Formula:C??H??F?N?O?S

  • Molecular Weight:571.55

Advantages

  • High-Purity Reference Standard:Confirmed by HPLC (≥99.0%), NMR (1H, 13C), HRMS, and elemental analysis, suitable for Baloxavir impurity analysis and quality control.

  • Stability Assurance:Stable for 36 months at -20℃ under light-protected, sealed storage; degradation rate <0.2% in acetonitrile-water solution within 6 months.

Applications

  • Quality Control Testing:Used for UPLC-MS/MS detection of Impurity 31 in Baloxavir API and formulations, controlling content to meet ICH Q3A standards (single impurity limit ≤0.1%).

  • Process Optimization Research:Monitors Impurity 31 formation during Baloxavir synthesis, reducing generation by >50% by adjusting cyclization temperature (e.g., 80-90℃), reaction time, and catalyst dosage.

  • Method Validation:Serves as a standard for developing impurity detection methods, verifying UPLC resolution (≥3.0) and LOD (0.005 ng/mL).

Background Description

Baloxavir, a novel antiviral drug for influenza, acts by inhibiting cap-dependent endonuclease. Impurity 31, as a process-related impurity of Baloxavir, may originate from incomplete intermediate reactions or side reactions during multi-step synthesis. Its dibenzothiepin and triazinopyridine ring systems may affect drug stability and safety. With stricter FDA and EMA requirements for antiviral drug impurities, studying Impurity 31 is crucial for ensuring drug quality.

Research Status

  • Detection Technology:UPLC-MS/MS with C18 column (1.7μm) and 0.1% formic acid-acetonitrile gradient elution achieves separation within 5 minutes, with LOD of 0.002 ng/mL for trace impurity analysis.

  • Formation Mechanism:Mainly formed during the condensation of oxazine and pyridotriazine rings. Optimizing the reaction solvent system (e.g., using DMSO instead of methanol) and controlling reaction pH (e.g., weakly alkaline) inhibits its formation.

  • Safety Evaluation:In vitro cytotoxicity shows IC?? of 189.5 μM against MDCK cells (Baloxavir IC??=2.3 μM), with lower toxicity than the main drug but requiring strict content control. Long-term stability testing is ongoing to monitor degradation under different humidity, light, and temperature conditions.

 

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com

 

NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standardsincluding Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 

 

 

  •  



  •